Strive Financial Group LLC Trims Stake in Globe Life Inc. $GL

Strive Financial Group LLC lowered its position in Globe Life Inc. (NYSE:GLFree Report) by 80.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,429 shares of the company’s stock after selling 9,815 shares during the quarter. Strive Financial Group LLC’s holdings in Globe Life were worth $434,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Concurrent Investment Advisors LLC bought a new stake in Globe Life during the second quarter valued at $204,000. NEOS Investment Management LLC increased its stake in Globe Life by 14.0% in the 2nd quarter. NEOS Investment Management LLC now owns 12,335 shares of the company’s stock worth $2,204,000 after acquiring an additional 1,512 shares during the last quarter. Nykredit A S bought a new position in Globe Life in the 2nd quarter worth about $636,000. Proficio Capital Partners LLC raised its holdings in shares of Globe Life by 12.3% in the 2nd quarter. Proficio Capital Partners LLC now owns 4,112 shares of the company’s stock valued at $735,000 after acquiring an additional 451 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC purchased a new stake in shares of Globe Life in the 2nd quarter valued at about $1,621,000. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Insider Transactions at Globe Life

In related news, CFO Thomas Kalmbach sold 21,000 shares of Globe Life stock in a transaction on Thursday, July 30th. The shares were sold at an average price of $180.06, for a total value of $3,781,260.00. Following the transaction, the chief financial officer owned 50,568 shares in the company, valued at $9,105,274.08. This trade represents a 29.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Cheryl Alston sold 8,258 shares of the business’s stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the completion of the sale, the director directly owned 16,621 shares of the company’s stock, valued at $2,979,148.04. This represents a 33.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 151,908 shares of company stock worth $27,239,981. Corporate insiders own 2.11% of the company’s stock.

Globe Life Price Performance

GL opened at $174.15 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $13.38 billion, a P/E ratio of 11.56 and a beta of 0.46. The stock has a 50-day moving average price of $178.54 and a 200-day moving average price of $160.60. Globe Life Inc. has a 12-month low of $127.85 and a 12-month high of $191.55.

Globe Life (NYSE:GLGet Free Report) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The firm had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The business’s quarterly revenue was up 8.0% on a year-over-year basis. During the same period in the prior year, the business posted $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities analysts predict that Globe Life Inc. will post 15.71 earnings per share for the current fiscal year.

Globe Life announced that its board has authorized a share repurchase plan on Monday, August 10th that authorizes the company to repurchase $2.50 billion in shares. This repurchase authorization authorizes the company to buy up to 17.7% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s management believes its stock is undervalued.

Globe Life Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be paid a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, October 5th. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is 8.76%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on GL shares. Keefe, Bruyette & Woods dropped their price target on Globe Life from $192.00 to $190.00 and set an “outperform” rating for the company in a research report on Friday, July 24th. TD Cowen raised their target price on shares of Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a research note on Wednesday, July 22nd. JPMorgan Chase & Co. lifted their target price on shares of Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a research report on Tuesday, July 21st. Piper Sandler boosted their price target on shares of Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 15th. Finally, Wells Fargo & Company increased their price target on shares of Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a report on Thursday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, Globe Life has an average rating of “Moderate Buy” and a consensus price target of $191.67.

Check Out Our Latest Research Report on GL

About Globe Life

(Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Read More

Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GLFree Report).

Institutional Ownership by Quarter for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.